Device Trial Radar · NCT02274896
Bayston Multicenter Antimicrobial PD Catheter Safety Study
Last checked: Nov 20, 2026Latest source record: Sep 15, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Nov 2014
Primary completion
Dec 2015
Study completion Dec 2015
Sponsor
- Lead sponsor
- Medical Components, Inc dba MedCompNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 24, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study was designed to establish the safety of the Bayston Antimicrobial PD catheter that is impregnated with a "cocktail" of three well known anti-microbials
Conditions
- End Stage Renal Disease (ESRD)
Interventions
PD Catheter groupDevice
PD catheter
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Adverse eventsTime frame: 6 months
Locations
5 sites in 3 countries. Site status is shown where the registry gives one.
UZ Leuven
Leuven, Belgium
University Medical Center Utrecht
Utrecht, Netherlands
North Bristol NHS Trust
Bristol, United Kingdom
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.